Literature DB >> 17392371

Suppression of viral gene expression in bovine leukemia virus-associated B-cell malignancy: interplay of epigenetic modifications leading to chromatin with a repressive histone code.

Makram Merimi1, Pavel Klener, Maud Szynal, Yvette Cleuter, Pierre Kerkhofs, Arsène Burny, Philippe Martiat, Anne Van den Broeke.   

Abstract

Ovine leukemia/lymphoma resulting from bovine leukemia virus infection of sheep offers a large animal model for studying mechanisms underlying leukemogenesis. Silencing of viral information including Tax, the major contributor to the oncogenic potential of the virus, is critical if not mandatory for tumor progression. In this study, we have identified epigenetic mechanisms that govern the complete suppression of viral expression, using a lymphoma-derived B-cell clone carrying a silent provirus. Silencing was not relieved by injection of the malignant B cells into sheep. However, exogenous expression of Tax or treatment with either the DNA methyltransferase inhibitor 5'azacytidine or the histone deacetylase (HDAC) inhibitor trichostatin A rescued viral expression, as demonstrated by in vivo infectivity trials. Comparing silent and reactivated provirus, we found mechanistic connections between chromatin conformation and tumor-associated transcriptional repression. Silencing is associated with DNA methylation and decreased accessibility of promoter sequences. HDAC1 and the transcriptional corepressor mSin3A are associated with the inactive but not the reactivated promoter. Silencing correlates with a repressed chromatin structure marked by histone H3 and H4 hypoacetylation, a loss of methylation at H3 lysine 4, and an increase of H3 lysine 9 methylation. These observations point to the critical role of epigenetic mechanisms in tumor-specific virus/oncogene silencing, a potential strategy to evade immune response and favor the propagation of the transformed cell.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392371      PMCID: PMC1900279          DOI: 10.1128/JVI.02606-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Histone deacetylase activity is required for full transcriptional repression by mSin3A.

Authors:  C A Hassig; T C Fleischer; A N Billin; S L Schreiber; D E Ayer
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

2.  Even transcriptionally competent proviruses are silent in bovine leukemia virus-induced sheep tumor cells.

Authors:  A Van den Broeke; Y Cleuter; G Chen; D Portetelle; M Mammerickx; D Zagury; M Fouchard; L Coulombel; R Kettmann; A Burny
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 3.  The BLV-induced leukemia--lymphosarcoma complex in sheep.

Authors:  S Djilali; A L Parodi
Journal:  Vet Immunol Immunopathol       Date:  1989-10       Impact factor: 2.046

4.  The CREB, ATF-1, and ATF-2 transcription factors from bovine leukemia virus-infected B lymphocytes activate viral expression.

Authors:  E Adam; P Kerkhofs; M Mammerickx; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences.

Authors:  R Kettmann; J Deschamps; Y Cleuter; D Couez; A Burny; G Marbaix
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

6.  Activation of bovine leukemia virus transcription in lymphocytes from infected sheep: rapid transition through early to late gene expression.

Authors:  M A Powers; K Radke
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

7.  Involvement of the cyclic AMP-responsive element binding protein in bovine leukemia virus expression in vivo.

Authors:  E Adam; P Kerkhofs; M Mammerickx; R Kettmann; A Burny; L Droogmans; L Willems
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  In vivo transfection of bovine leukemia provirus into sheep.

Authors:  L Willems; D Portetelle; P Kerkhofs; G Chen; A Burny; M Mammerickx; R Kettmann
Journal:  Virology       Date:  1992-08       Impact factor: 3.616

9.  Bovine leukemia virus, an animal model for the study of intrastrain variability.

Authors:  L Willems; E Thienpont; P Kerkhofs; A Burny; M Mammerickx; R Kettmann
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  In vivo infection of sheep by bovine leukemia virus mutants.

Authors:  L Willems; R Kettmann; F Dequiedt; D Portetelle; V Vonèche; I Cornil; P Kerkhofs; A Burny; M Mammerickx
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more
  10 in total

1.  DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: potential involvement of direct inhibition of cAMP-responsive element (CRE)-binding protein/CRE modulator/activation transcription factor binding.

Authors:  Valérie Pierard; Allan Guiguen; Laurence Colin; Gaëlle Wijmeersch; Caroline Vanhulle; Benoît Van Driessche; Ann Dekoninck; Jana Blazkova; Christelle Cardona; Makram Merimi; Valérie Vierendeel; Claire Calomme; Thi Liên-Anh Nguyên; Michèle Nuttinck; Jean-Claude Twizere; Richard Kettmann; Daniel Portetelle; Arsène Burny; Ivan Hirsch; Olivier Rohr; Carine Van Lint
Journal:  J Biol Chem       Date:  2010-04-22       Impact factor: 5.157

2.  Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma.

Authors:  Nicolas Rosewick; Mélanie Momont; Keith Durkin; Haruko Takeda; Florian Caiment; Yvette Cleuter; Céline Vernin; Franck Mortreux; Eric Wattel; Arsène Burny; Michel Georges; Anne Van den Broeke
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

3.  Characterization of novel Bovine Leukemia Virus (BLV) antisense transcripts by deep sequencing reveals constitutive expression in tumors and transcriptional interaction with viral microRNAs.

Authors:  Keith Durkin; Nicolas Rosewick; Maria Artesi; Vincent Hahaut; Philip Griebel; Natasa Arsic; Arsène Burny; Michel Georges; Anne Van den Broeke
Journal:  Retrovirology       Date:  2016-05-03       Impact factor: 4.602

Review 4.  Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV.

Authors:  Sabrina M Rodríguez; Arnaud Florins; Nicolas Gillet; Alix de Brogniez; María Teresa Sánchez-Alcaraz; Mathieu Boxus; Fanny Boulanger; Gerónimo Gutiérrez; Karina Trono; Irene Alvarez; Lucas Vagnoni; Luc Willems
Journal:  Viruses       Date:  2011-07-19       Impact factor: 5.048

5.  Chromatin disruption in the promoter of bovine leukemia virus during transcriptional activation.

Authors:  Laurence Colin; Ann Dekoninck; Michal Reichert; Miriam Calao; Makram Merimi; Anne Van den Broeke; Valérie Vierendeel; Yvette Cleuter; Arsène Burny; Olivier Rohr; Carine Van Lint
Journal:  Nucleic Acids Res       Date:  2011-09-02       Impact factor: 16.971

6.  Chemoresistance to Valproate Treatment of Bovine Leukemia Virus-Infected Sheep; Identification of Improved HDAC Inhibitors.

Authors:  Nicolas Gillet; Fabian Vandermeers; Alix de Brogniez; Arnaud Florins; Annamaria Nigro; Carole François; Amel-Baya Bouzar; Olivier Verlaeten; Eric Stern; Didier M Lambert; Johan Wouters; Luc Willems
Journal:  Pathogens       Date:  2012-10-08

7.  Animal models on HTLV-1 and related viruses: what did we learn?

Authors:  Hiba El Hajj; Rihab Nasr; Youmna Kfoury; Zeina Dassouki; Roudaina Nasser; Ghada Kchour; Olivier Hermine; Hugues de Thé; Ali Bazarbachi
Journal:  Front Microbiol       Date:  2012-09-21       Impact factor: 5.640

8.  Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection.

Authors:  Nicolas A Gillet; Gerónimo Gutiérrez; Sabrina M Rodriguez; Alix de Brogniez; Nathalie Renotte; Irene Alvarez; Karina Trono; Luc Willems
Journal:  PLoS Pathog       Date:  2013-10-03       Impact factor: 6.823

9.  Characterization of new RNA polymerase III and RNA polymerase II transcriptional promoters in the Bovine Leukemia Virus genome.

Authors:  Benoit Van Driessche; Anthony Rodari; Nadège Delacourt; Sylvain Fauquenoy; Caroline Vanhulle; Arsène Burny; Olivier Rohr; Carine Van Lint
Journal:  Sci Rep       Date:  2016-08-22       Impact factor: 4.379

Review 10.  Regulation of Expression and Latency in BLV and HTLV.

Authors:  Aneta Pluta; Juan P Jaworski; Renée N Douville
Journal:  Viruses       Date:  2020-09-25       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.